Risk factors
Arcutis Biotherapeutics (ARQT) risk factors
Item 1A of every Arcutis Biotherapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors64 risks1 new1 dropped10 reworded
Intellectual-property litigation risk now expressly includes alleged misappropriation of third-party confidential information and trade secrets.
Filed Feb 25, 2026 - FY2024 10-K risk factors69 risks
Commercial success depends heavily on expanding ZORYVE sales and securing physician, patient, and payer acceptance.
Filed Feb 25, 2025